Proteomics urine analysis of pregnant women suffering from multiple sclerosis

Journal of Proteome Research

Volumn 14, Issue 5, 2015, Pages 2065-2073

  Singh, Vaibhav ^a   Stingl, Christoph ^a   Stoop, Marcel P ^a   Zeneyedpour, Lona ^a   Neuteboom, Rinze F ^a   Smitt, Peter Sillevis ^a   Hintzen, Rogier Q ^a   Luider, Theo M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

mass spectrometry; multiple sclerosis; postpartum period; pregnancy; third trimester; urine

Indexed keywords

GAMMA GLUTAMYL HYDROLASE; IMMUNOGLOBULIN MU CHAIN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; TREFOIL FACTOR 3; TREFOIL PEPTIDE; UNCLASSIFIED DRUG; CARBOXYPEPTIDASE; CELL SURFACE RECEPTOR; LAMP2 PROTEIN, HUMAN; OSCAR PROTEIN, HUMAN; PEPTIDE; PEPTIDE FRAGMENT; PROTEOME; TFF3 PROTEIN, HUMAN; TRYPSIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INNATE IMMUNITY; INVESTIGATIVE PROCEDURES; LONGITUDINAL STUDY; MASS SPECTROMETRY; MULTIPLE SCLEROSIS; OSTEOCLAST; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; PUERPERIUM; THIRD TRIMESTER PREGNANCY; URINALYSIS; CHEMISTRY; GENE EXPRESSION; GENETICS; ISOLATION AND PURIFICATION; LIQUID CHROMATOGRAPHY; METABOLISM; PATHOLOGY; PREGNANCY; TANDEM MASS SPECTROMETRY; URINE;

LOTUS;

ADULT; CARBOXYPEPTIDASES; CHROMATOGRAPHY, LIQUID; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOGLOBULIN MU-CHAINS; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2; MULTIPLE SCLEROSIS; PEPTIDE FRAGMENTS; PEPTIDES; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PROTEOME; RECEPTORS, CELL SURFACE; TANDEM MASS SPECTROMETRY; TRYPSIN; URINALYSIS;

EID: 84929658281     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr501162w     Document Type: Article

References (36)

1. Compston, A.; Coles, A. Multiple sclerosis Lancet 2002, 359 (9313) 1221-1231
2. Confavreux, C.; Hutchinson, M.; Hours, M. M.; Cortinovis-Tourniaire, P.; Moreau, T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group N. Engl J. Med. 1998, 339 (5) 285-291
3. Harbo, H. F.; Gold, R.; Tintore, M. Sex and gender issues in multiple sclerosis Ther. Adv. Neurol. Disord. 2013, 6 (4) 237-248
4. Vukusic, S.; Confavreux, C. Pregnancy and multiple sclerosis: the children of PRIMS Clin. Neurol. Neurosurg. 2006, 108 (3) 266-270
5. Vukusic, S.; Hutchinson, M.; Hours, M.; Moreau, T.; Cortinovis-Tourniaire, P.; Adeleine, P.; Confavreux, C. The Pregnancy In Multiple Sclerosis, G.; Pregnancy In Multiple Sclerosis, G., Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse Brain 2004, 127 (Pt 6) 1353-1360
6. Voskuhl, R. R.; Gold, S. M. Sex-related factors in multiple sclerosis susceptibility and progression Nat. Rev. Neurol. 2012, 8 (5) 255-263
7. Kipp, M.; Amor, S.; Krauth, R.; Beyer, C. Multiple sclerosis: neuroprotective alliance of estrogen-progesterone and gender Front. Neuroendocrinol. 2012, 33 (1) 1-16
8. Ponsonby, A. L.; Lucas, R. M.; van der Mei, I. A.; Dear, K.; Valery, P. C.; Pender, M. P.; Taylor, B. V.; Kilpatrick, T. J.; Coulthard, A.; Chapman, C.; Williams, D.; McMichael, A. J.; Dwyer, T. Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune Study Neurology 2012, 78 (12) 867-874
9. Sicotte, N. L.; Liva, S. M.; Klutch, R.; Pfeiffer, P.; Bouvier, S.; Odesa, S.; Wu, T. C.; Voskuhl, R. R. Treatment of multiple sclerosis with the pregnancy hormone estriol Ann. Neurol. 2002, 52 (4) 421-328
10. Soldan, S. S.; Alvarez Retuerto, A. I.; Sicotte, N. L.; Voskuhl, R. R. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol J. Immunol. 2003, 171 (11) 6267-6274
11. Patas, K.; Engler, J. B.; Friese, M. A.; Gold, S. M. Pregnancy and multiple sclerosis: feto-maternal immune cross talk and its implications for disease activity J. Reprod. Immunol. 2013, 97 (1) 140-146
12. Neuteboom, R. F.; Verbraak, E.; Wierenga-Wolf, A. F.; van Meurs, M.; Steegers, E. A.; de Groot, C. J.; Laman, J. D.; Hintzen, R. Q. Pregnancy-induced fluctuations in functional T-cell subsets in multiple sclerosis patients Mult. Scler. 2010, 16 (9) 1073-1078
13. Gilli, F.; Lindberg, R. L.; Valentino, P.; Marnetto, F.; Malucchi, S.; Sala, A.; Capobianco, M.; di Sapio, A.; Sperli, F.; Kappos, L.; Calogero, R. A.; Bertolotto, A. Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis PLoS One 2010, 5 (1) e8962
14. Brynedal, B.; Khademi, M.; Wallstrom, E.; Hillert, J.; Olsson, T.; Duvefelt, K. Gene expression profiling in multiple sclerosis: a disease of the central nervous system, but with relapses triggered in the periphery? Neurobiol. Dis. 2010, 37 (3) 613-621
15. Broker, M. E.; Lalmahomed, Z. S.; Roest, H. P.; van Huizen, N. A.; Dekker, L. J.; Calame, W.; Verhoef, C.; Ijzermans, J. N.; Luider, T. M. Collagen peptides in urine: a new promising biomarker for the detection of colorectal liver metastases PLoS One 2013, 8 (8) e70918
16. R Core Team R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2014. http://www.R-project.org/.
17. Thongboonkerd, V. Practical points in urinary proteomics J. Proteome Res. 2007, 6 (10) 3881-3890
18. Dobson, R. Urine: An under-studied source of biomarkers in multiple sclerosis? Mult. Scler. Relat. Disord. 2012, 1 (2) 76-80
19. Fliser, D.; Novak, J.; Thongboonkerd, V.; Argiles, A.; Jankowski, V.; Girolami, M. A.; Jankowski, J.; Mischak, H. Advances in urinary proteome analysis and biomarker discovery J. Am. Soc. Nephrol 2007, 18 (4) 1057-1071
20. Neuteboom, R. F.; Verbraak, E.; Wierenga-Wolf, A. F.; Voerman, J. S.; Meurs, M.; Swagemakers, S. M.; van de Spek, P. J.; Steegers, E. A.; de Groot, C. J.; Laman, J. D.; Hintzen, R. Q. The monocyte transcriptome during pregnancy in multiple sclerosis: prominent expression of the Fc-receptor CD64 Mult. Scler. 2011, 17 (4) 389-396
21. Belle, A.; Tanay, A.; Bitincka, L.; Shamir, R.; O'Shea, E. K. Quantification of protein half-lives in the budding yeast proteome Proc. Natl. Acad. Sci. U. S. A. 2006, 103 (35) 13004-13009
22. Snyder, S. K.; Wessner, D. H.; Wessells, J. L.; Waterhouse, R. M.; Wahl, L. M.; Zimmermann, W.; Dveksler, G. S. Pregnancy-specific glycoproteins function as immunomodulators by inducing secretion of IL-10, IL-6 and TGF-beta1 by human monocytes Am. J. Reprod. Immunol. 2001, 45 (4) 205-216
23. Abramsky, O. Pregnancy and multiple sclerosis Ann. Neurol. 1994, 36 (Suppl) S38-S41
24. Hallast, P.; Rull, K.; Laan, M. The evolution and genomic landscape of CGB1 and CGB2 genes Mol. Cell. Endocrinol. 2007, 260-262, 2-11
25. Rull, K.; Hallast, P.; Uuskula, L.; Jackson, J.; Punab, M.; Salumets, A.; Campbell, R. K.; Laan, M. Fine-scale quantification of HCG beta gene transcription in human trophoblastic and non-malignant non-trophoblastic tissues Mol. Hum. Reprod. 2008, 14 (1) 23-31
26. Avolio, C.; Ruggieri, M.; Giuliani, F.; Liuzzi, G. M.; Leante, R.; Riccio, P.; Livrea, P.; Trojano, M. Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes J. Neuroimmunol. 2003, 136 (1-2) 46-53
27. Liuzzi, G. M.; Trojano, M.; Fanelli, M.; Avolio, C.; Fasano, A.; Livrea, P.; Riccio, P. Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis Mult. Scler. 2002, 8 (3) 222-228
28. Bebo, B. F., Jr.; Dveksler, G. S. Evidence that pregnancy specific glycoproteins regulate T-Cell function and inflammatory autoimmune disease during pregnancy Curr. Drug Targets: Inflammation Allergy 2005, 4 (2) 231-237
29. Samson, M. H.; Vestergaard, E. M.; Milman, N.; Poulsen, S. S.; Nexo, E. Circulating serum trefoil factors increase dramatically during pregnancy Scand. J. Clin. Lab. Invest. 2008, 68 (5) 369-374
30. Barrera, G. J.; Sanchez, G.; Gonzalez, J. E. Trefoil factor 3 isolated from human breast milk downregulates cytokines (IL8 and IL6) and promotes human beta defensin (hBD2 and hBD4) expression in intestinal epithelial cells HT-29 Bosnian J. Basic Med. Sci. 2012, 12 (4) 256-264
31. Gandhi, R.; Laroni, A.; Weiner, H. L. Role of the innate immune system in the pathogenesis of multiple sclerosis J. Neuroimmunol. 2010, 221 (1-2) 7-14
32. Arruda, L. B.; Sim, D.; Chikhlikar, P. R.; Maciel, M., Jr.; Akasaki, K.; August, J. T.; Marques, E. T. Dendritic cell-lysosomal-associated membrane protein (LAMP) and LAMP-1-HIV-1 gag chimeras have distinct cellular trafficking pathways and prime T and B cell responses to a diverse repertoire of epitopes J. Immunol. 2006, 177 (4) 2265-2275
33. Stoop, M. P.; Singh, V.; Stingl, C.; Martin, R.; Khademi, M.; Olsson, T.; Hintzen, R. Q.; Luider, T. M. Effects of natalizumab treatment on the cerebrospinal fluid proteome of multiple sclerosis patients J. Proteome Res. 2013, 12 (3) 1101-1107
34. Rahn, K. A.; Watkins, C. C.; Alt, J.; Rais, R.; Stathis, M.; Grishkan, I.; Crainiceau, C. M.; Pomper, M. G.; Rojas, C.; Pletnikov, M. V.; Calabresi, P. A.; Brandt, J.; Barker, P. B.; Slusher, B. S.; Kaplin, A. I. Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis Proc. Natl. Acad. Sci. U. S. A. 2012, 109 (49) 20101-20106
35. Mc Guire, C.; Prinz, M.; Beyaert, R.; van Loo, G. Nuclear factor kappa B (NF-kappaB) in multiple sclerosis pathology Trends Mol. Med. 2013, 19 (10) 604-613
36. Bagnato, F.; Durastanti, V.; Finamore, L.; Volante, G.; Millefiorini, E. Beta-2 microglobulin and neopterin as markers of disease activity in multiple sclerosis Neurol. Sci. 2003, 24 (Suppl 5) S301-S304